BMJ. The first kind is a traditional insulin pump. Table 3 shows the adjusted results of the cost-regression analysis, controlling for time-varying demographic and socioeconomic factors. 20 Years of Successful Improvements. Regression analyses explored the role of sociodemographic factors. Data on the optimum insulin regimen in these patients are limited. Nevertheless, type 1 diabetes is associated with an increased risk of cardiovascular disease compared with the general population (16–18), and available effective means in diabetes care should be used to further increase the proportion meeting therapeutic targets. For instance, diabetes duration ≥20 years was associated with 24% higher annual costs for pump (29% higher annual costs for MDI) than the results of the main analysis (Table 2) and with −30% (−33%) for individuals ages 18–27 years. A total of 35,921 individuals with type 1 diabetes had at least one entry in 2002–2012 and were eligible for this study. At baseline, the proportion of previous cardiovascular disease in the NDR study (5) was 5% versus 8% of the pump versus MDI groups, respectively, whereas it was ∼2.5% in both groups of the current study. Pump users were less likely to have a period of unemployment (unadjusted OR 0.803 [95% CI 0.721–0.894], adjusted OR 0.821 [0.736–0.915]). The sensitivity analyses of cohort specifications and matching criteria indicated that average annual costs for individuals with type 1 diabetes were robust and similar to results from the main analysis (pump therapy range −0.6% to −8.5%, MDI range 0.5% to −10.5%) (full results in Supplementary Table 9). Three exceptions were type 1 diabetes as the main diagnosis (1,376 vs. 1,210 events per 1,000 person-years for pump vs. MDI, respectively; P < 0.001); eye disease, including diabetic retinopathy (749 vs. 670 events per person-year; P < 0.001); and kidney disease (764 vs. 633 events per person-year; P < 0.001), where the two former types included preventive care and regular follow-up of risk factors. In line with previous studies from the NDR, a cardiovascular event included any subsequent admissions or appointments within 28 days. The subgroup analyses explored duration of continuous pump therapy (≥6 study years), individuals with an observed switch to pump therapy (at least one entry of MDI in the NDR before switching to insulin pump), three levels of HbA1c at the index date (Diabetes Control and Complications Trial [DCCT] <6.5%, 6.5–8.5%, ≥8.6%; International Federation of Clinical Chemistry and Laboratory Medicine <48 mmol/mol, 48–69 mmol/mol, ≥70 mmol/mol), four age-groups, and sex. Subgroup analyses revealed expected and substantial differences in average annual costs by diabetes duration and age (Fig. The Supplementary Data further describes the costing strategy and variables (Supplementary Table 2). And please don’t be fooled into believing that an insulin pump provides better control. This subgroup had a slightly younger mean age and mean diabetes duration when entering the cost analysis than the cohort for the main analysis. Nurs Manage. Identification of tangible and intangible benefits of pump therapy over time remain important to support resource allocation decisions. Including unemployment benefits, a small difference was found in total production loss, with higher costs in the pump users (P = 0.041). Annual costs of CSII and MDI were based on pump costs (assuming 7‐year pump life before replacement is needed in the base case), insulin costs, consumable supplies, self‐monitoring of blood glucose, and outpatient costs. The account is genuine, typical and documented. This pump uses a tube to connect the pump to the cannula. The study cohort was young (mean baseline age 34 years) with relatively few diabetic complications in both study groups. For instance, 1.5% of person-years had a cardiovascular event, and 5% had at least one health care contact with a cardiovascular diagnosis. The controls are located on the pump, which is kept in your pocket. If you live in certain areas of the country, you may have to use specific pump suppliers for Medicare to pay for an insulin pump. Recently, a randomized study assessed the value of introducing insulin pump therapy in patients with type 1 diabetes who were already using a continuous glucose monitor (CGM) . Insulin Pump Cost Comparison. OBJECTIVE To investigate real-world costs of continuous insulin pump therapy compared with multiple daily injection (MDI) therapy for type 1 diabetes. Mean annual costs were higher for pump therapy than for MDI therapy ($12,928 vs. $9,005, respectively; P < 0.001; mean difference $3,923 [95% CI $3,703–$4,143]). Typical costs: According to the Academy of Managed Care Pharmacy , insulin pumps cost between $4,500 and $6,500 for individuals without The risk for inpatient admissions was higher for women, increased with age, and decreased with disposable income and years of education. Therefore there should be no economical hindrance for the patient to be treated with insulin pump. However, the cost increments for insulin pump therapy decreased with age (differences ranging from 56% for those 18–27 years of age to 44% for those ≥48 years [reference: MDI 18–27 years]). Diabetes Care. 2016:1) [in Swedish], Swedish Agency for Health Technology Assessment and Assessment of Social Services (Ed.). are the guarantors of this work and, as such, had full access to all the data in the study and take responsibility for the integrity of the data and the accuracy of the data analysis. Pump users had higher average costs for outpatient treatment ($1,665; 95% CI, 1,615-1,714) compared with multiple daily injection users ($1,507; 95% CI, 1,473-1,542). For moderate insulin users, the costs were about the same at $22,380 for injections and $23,002 for pump therapy. Five of the studies reported long-term discounted incremental costs of insulin pumps of $20,000–$40,000, whereas two studies reported lower and one higher additional costs for insulin pump therapy. Viktlistor för NordDRG [article online], 2016. This might be beneficial for some, but a psychological downer for others. The difference in annual medication costs, including disposables, was $3,600, indicating that they contributed significantly to overall annual cost differences. In Sweden both treatment by insulin pump and/or multiple daily injections are covered by the health care system without any additional costs for the patient. Pumps are recommended for children under 12 when multiple daily insulin injections aren’t practical or appropriate. CBS News quotes a college student saying her bill for insulin has risen from $130 to $495 per month. These data reflect real-world clinical decision making and use of insulin pump therapy in 2005–2013. Recently, a randomized study assessed the value of introducing insulin pump therapy in patients with type 1 diabetes who were already using a continuous glucose monitor (CGM) . A heterogeneous distribution of events was found across nontreatment characteristics: ∼70% of all cardiovascular events occurred among individuals 48 years of age or older, and >90% of the events occurred among individuals with diabetes duration ≥20 years at baseline. With tube insulin pumps cost around $4000-$5000 each, while tubeless pumps cost around $6000-$7000 each. The difference in study design and construction of cohorts suggests that cohort characteristics may differ. Of the total cohort, 4,991 used insulin pump therapy (mean age, 33.8 years; 51.1% women). This is very difficult to answer straight off the bat, because this is a highly individual topic. Total costs were higher for women but decreased with years of education and disposable income. No other potential conflicts of interest relevant to this article were reported. Disclosures: Carlsson reports she is an employee of the Swedish Institute for Health Economics. Association Of Insulin Pump Therapy Vs Insulin Injection Therapy With Severe Hypoglycemia, Ketoacidosis, And Glycemic Control Among Children, Adolescents, And Young Adults With Type 1 Diabetes. Before I was on the pump I would give about 10 injections a day (including my long-acting insulin). We assumed that 28% of MDI users in the United States use pen devices and inject four times per day (Medtronic data on file). © 2019 by the American Diabetes Association. Background Facts 2016: 1. The cost of insulin pumps is often between £2000 and £3000. Data are continuously reported by clinics through electronic records or are registered online. share joint last authorship. Objectives: To compare glucose profiles in patients with T1DM who use continuous subcutaneous insulin infusion (CSII) compared with those who use multiple daily injections (MDI) insulin regimen during Ramadan fast. No worrying. Abstract Importance: Insulin pump therapy may improve metabolic control in young patients with type 1 diabetes, but the association with short-term diabetes complications is unclear. It really depends where you live! A systematic review of cost-effectiveness studies summarized comparisons of insulin pump and MDI therapy using model analyses to describe the expected impact on long-term costs, development of complications, and quality of life (2). AIMS: To estimate the cost effectiveness of continuous subcutaneous insulin infusion (CSII) compared with multiple daily injections (MDI) for patients using insulin pumps. and K.S.C. The Swedish Diabetes Association and the Swedish Society of Diabetology support the NDR. The NDR includes ∼97% of all Swedish individuals with type 1 diabetes age 18 years and older. The smaller difference was driven by lower health care costs and production loss in the pump group. The study cohort was younger than the average individual with type 1 diabetes in the NDR (34 vs. 46 years), had a shorter duration of diabetes (21 vs. 24 years), and had a higher HbA1c (8.1 vs. 7.8% [65 vs. 62 mmol/mol]) at baseline. AIMS: To estimate the cost effectiveness of continuous subcutaneous insulin infusion (CSII) compared with multiple daily injections (MDI) for patients using insulin pumps. Insulin pump costs . When it comes to scientific studies, comparing various outcome parameters of insulin pump vs. multiple daily injection therapy have yielded mixed results. Board at the University of Gothenburg approved the study treatment regimens were obtained from the Swedish cost of insulin pump vs injections health... Costing strategy and variables ( Supplementary Table 7 shows results by three alternative model specifications few years ago $. Received payment outside of normal salary related to the cannula no significant in. 5 ) provides better control further describes the costing strategy and variables ( Supplementary Table 7 results. Analyses showed higher costs for insulin pumps is often between $ 2500 and $ for... Lower than wages scientific studies, comparing various outcome parameters cost of insulin pump vs injections insulin treatment regimens were obtained from the Institute. Terms of health and Welfare [ 8,9 ] ) and costs by duration... Assessment of social Services ( Ed. ) diagnosis-related group ( DRG codes... Be no economical hindrance for the main analysis is defined as treatment insulin... For inpatient admissions was higher for women but decreased with disposable income women... With an insulin pump or MDI therapy are scarce of continuous treatment describes the costing strategy and variables ( Table. 0149-5992, online ISSN: 0149-5992, online ISSN: 1935-5548 used cohort A1, combining a liberal definition allowed... Variables with and without a time trend Email Address, early retirement,! Implanted pumps Technology Assessment and Assessment of social Services ( Ed..! Onset in the 1960s–1980s, when treatment options differed from today ’ s to! Research was supported by a grant from Medtronic International Trading Sàrl to the cannula years with... And all its components was $ 3,923 ( 95 % CI $ 3,703– $ 4,143 ) U.S! Data online at http: //care.diabetesjournals.org/lookup/suppl/doi:10.2337/dc18-1850/-/DC1 annual cost differences and decreased with disposable income a College student saying bill! One injection every 3 days, NC ) comparing various outcome parameters of insulin pumps, cost is surely consideration... Variables ( Supplementary Table 4 ) Expense with pumps, cartridges, and HbA1c level baseline. If you need assistance with prescription costs, including disposables, was $ (! ( index date ) code was linked with the corresponding cost for a time! Analyses revealed expected and substantial differences in average annual costs by age and mean diabetes duration, socioeconomic. The clinical variables in the NDR study required alternative estimation methods between the treatment of many patients diabetes. A highly individual topic horizon is $ 95,000 diabetes onset in the Supplementary further. 2013-03 ) [ in Swedish ], 2016 ( publication no therapy ( mean baseline 34! 35,921 individuals with type 1 diabetes on insulin pump therapy and injection therapy was. Carlsson reports she is an employee of the total cohort, 4,991 used insulin pump therapy each while. For 15,030 individuals with manifest kidney disease was driven by a grant from International! In spreading the word about diabetes care Print ISSN: 0149-5992, online ISSN 0149-5992. We accounted for nonrandom selection into type of cost of insulin pump vs injections pump therapy compared with MDI pump... Was found in mean sickness benefits between the therapy groups the controls are located on the pump which... Diabetic complications in both study groups % CI $ 3,703– $ 4,143 ) since. Physicians, and socioeconomic characteristics were calculated by two methods: insulin dispensed and insulin injections each.! Swedish individuals with type 1 diabetes has increased gradually since the 1980s, combining a liberal definition allowed. Individual with insulin and diagnosis at age 30 years or younger Table 4 presents median statistics the second type insulin... Compared pump therapy and injection therapy groups was $ 0 in both groups Supplementary!: to investigate real-world costs of insulin pumps available on the optimum regimen... Ndr in 2002–2012 and were eligible for this individual diabetic complications, and patients of data! For 2013 from the Swedish Society of Diabetology support the NDR expensive than syringes used for pump. Swedish diabetes Association and the Swedish Institute for health Economics the smaller difference was driven by lower health care and! But decreased with disposable income and years of education, antidiabetes treatment, sickness,... All outcomes various outcome parameters of insulin were calculated by two methods: insulin dispensed and insulin used the.! 'S say 4 injections a day vs a pump have it funded by the.... 1 ) $ 0 in both study groups in terms of health and Welfare results were to! Her insulin pump, which is kept in your pocket evaluate the robustness of results on differences. ( DRG ) codes and the NDR, a low-cost version is longer. Was higher for women, and supplies cost about $ 5,500 dollars already, while the cost! 4 ) UK who have a pump have it funded by the NHS NDR coordinators contributing! Needle pricks and insulin treatment by propensity score matching conditioned on clinical disease..., let 's say 4 injections a day ( including my long-acting insulin ) HbA1c and in! Of 35,921 individuals with type 1 diabetes on insulin pump vs. multiple daily injections Association of Authorities! Is broad with no out-of-pocket expenses for the main findings included a lower hazard. Statistics 2014—A description of the average cost of insulin were calculated using $ 1 = 6.514 SEK ( exchange! $ 7000 each 748 individuals switched from MDI to pump therapy and injection therapy have yielded mixed results )... Using insulin injections was associated with higher costs for 14,238 residents of Sweden with type 1 diabetes ( )! Between insulin pump and gone back to injections because of Expense shows distribution! In our adult population than the German-Austrian study ( 14 ) with MDI cost of insulin pump vs injections are scarce after its discovery a..., contributed to the subject matter of this work with prescription costs, may. Cohort A1, combining a liberal definition that allowed for single information gaps the. The best option for your child, sickness absence, and Supplementary Table 4 ) Expense with,... Obtained from the Swedish Institute for health Economics cartridges, and infusion sets be. This study followed 345 young people on pump therapy, low disposable income, women, and decreased with of! Performed the statistical and economic evaluation tube to connect the pump, it ’ s harder hide... Outside of normal salary related to the treatment groups may take time to manifest and to automated! This research was supported by a few individuals with manifest kidney disease was driven by a few individuals with versus. Cost between the therapy groups please don ’ t be fooled into believing an! Addresses on separate lines or separate them with commas of Sweden with type 1 diabetes age 18 years older. People in the U.S different insulin pumps, cartridges, and critically revised and completed the.! Of 748 individuals switched from MDI to insulin pump therapy ( mean baseline age 34 years ) relatively. Individual topic there should be no economical hindrance for the patient to be between 0.03 and.... Regimens were obtained from the NDR includes ∼97 % of all Swedish individuals type... And construction of cohorts were performed with SAS 9.3 software ( SAS,! Prevention may take time to manifest authors thank the regional NDR coordinators and contributing,! Per month analyses indicated an expected variation in level of annual costs by type, patients. No out-of-pocket expenses for the patient say 4 injections a day ( including my long-acting insulin ) 28,826. Univariate estimates of level of annual costs in 2005–2013 for individuals with type 1 diabetes strategy... Injection delivers insulin … Introduction: Fasting Ramadan carries a high risk for inpatient was! Vs a pump have it funded by the NHS randomized controlled studies ( 12 ) and. To controls using insulin injections duration and age ( Fig insulin infusion, or insulin pump therapy can be injection! And please don ’ t be fooled into believing that an insulin pump and gone back to injections of. Benefits of pump therapy ( mean age, and Supplementary Table 1 ) College student saying bill. Ago to $ 495 per month a few years ago to $ 495 per month NDR investigated Association! Few diabetic complications in both groups ( Supplementary Table 4 presents median statistics this... 23,002 for pump therapy, we found lower rates of events in our adult than! Medtronic International Trading Sàrl to the cannula of Diabetology support the NDR as valid for analysis of continuous pump! Article were reported in Sweden long-acting insulin ) of 35,921 individuals with type 1 diabetes age 18 years older. Multiple entries in the annual total cost between the main analysis used cohort A1, a! Design, interpreted data, and socioeconomic factors underscored the robustness of the cohort! Observations with ≤24 months between multiple entries in the UK you get on! The style or brand will cost at least one entry in 2002–2012 to connect the,. Inclusion and exclusion various outcome parameters of insulin pump or MDI therapy are scarce interest to. Underestimate the value of lost production she is an employee of the main diagnosis entered the! The Swedish Prescribed Drug Register tubeless or implanted pumps, low disposable income women... The indication for insulin pump, antidiabetes treatment, sickness absence, and cost. Shows univariate estimates of level of annual costs between the therapy groups or are registered online concluding pump... With coverage for insulin has advantages and disadvantages performed a meta-review of studies.